Literature DB >> 6150332

Outbreak of paralytic poliomyelitis, Taiwan.

R J Kim-Farley, G Rutherford, P Lichfield, S T Hsu, W A Orenstein, L B Schonberger, K J Bart, K J Lui, C C Lin.   

Abstract

Taiwan had been free of major poliomyelitis outbreaks since 1975, but from May 29 to Oct 26, 1982, 1031 cases of type 1 paralytic poliomyelitis were reported to the Taiwan health authorities. Before the outbreak approximately 80% of infants had received at least 2 doses of trivalent oral poliovaccine (OPV) by their first birthday. Of the 86% of poliomyelitis patients whose vaccination status was known 65% had not had poliovaccine, 19% had received one dose, 8% had received two doses, and 8% had received three or more doses. Vaccine efficacy was calculated to be 82% after one dose, 96% after two doses, and 98% after three or more doses. Failure to vaccinate rather than vaccine failure was the most important risk factor in this outbreak. A child who had not had any vaccine was 80 times more likely to become a case than one who had received three or more doses of poliovaccine, independent of sanitation facilities at home. A child was 5 times more likely to become a case if he received water from non-municipal rather than municipal sources. Furthermore, for children who received municipal water, the risk was doubled if the family shared a toilet with at least one other family. This outbreak shows that major epidemics can occur in areas that have high overall community vaccination levels. Identification and vaccination of subpopulations with low coverage is essential for the control of poliomyelitis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150332     DOI: 10.1016/s0140-6736(84)90831-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study.

Authors:  Jiunn-Horng Kang; Herng-Ching Lin
Journal:  J Neurol       Date:  2011-01-30       Impact factor: 4.849

Review 2.  Primary prevention and international travel: infections, immunizations, and antimicrobial prophylaxis.

Authors:  G S Ferenchick; D H Havlichek
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

3.  Immune status of the population to poliovirus infection in Singapore.

Authors:  K T Goh; S Yamazaki
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.

Authors:  Chen-Fu Yang; Hour-Young Chen; Jaume Jorba; Hui-Chih Sun; Su-Ju Yang; Hsiang-Chi Lee; Yhu-Chering Huang; Tzou-Yien Lin; Pei-Jer Chen; Hiroyuki Shimizu; Yorihiro Nishimura; Andi Utama; Mark Pallansch; Tatsuo Miyamura; Olen Kew; Jyh-Yuan Yang
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  The case for global eradication of poliomyelitis.

Authors:  A R Hinman; W H Foege; C A de Quadros; P A Patriarca; W A Orenstein; E W Brink
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Winning the war against paralytic poliomyelitis.

Authors:  A Wegmann; R Glück
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

7.  Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.

Authors:  M Osei-Kwasi; E A Afari; K Mimura; I Obeng-Ansah; W K Ampofo; F K Nkrumah
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

8.  Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.

Authors:  N Deivanayagam; K Nedunchelian; S S Ahamed; S R Rathnam
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

Review 9.  Factors associated with missed vaccination during mass immunization campaigns.

Authors:  William M Weiss; Peter J Winch; Gilbert Burnham
Journal:  J Health Popul Nutr       Date:  2009-06       Impact factor: 2.000

10.  Evaluating the experience of GAPS--a methodology for improving quality of mass immunization campaigns in developing countries.

Authors:  William M Weiss; Gilbert Burnham; Peter J Winch
Journal:  J Health Popul Nutr       Date:  2009-10       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.